20 Jan 2022
Oncocyte Corporation (Irvine, CA, USA) has entered into a development and co-marketing agreement for two distributed in vitro diagnostic (IVD) assays on Thermo Fisher Scientific’s (Waltham, MA, USA) Ion Torrent Genexus System. The agreement also grants Oncocyte rights to develop future companion diagnostics on the Genexus System.
Más信息
2021年9月22日
Thermo Fisher Scientific Inc.(美国马萨诸塞州沃尔瑟姆)启动了世界上第一个完全集成的数字PCR(DPCR)系统,旨在在90分钟内提供高度准确,一致的结果。
Más信息
20 Jan 2021
Thermo Fisher Scientific Inc.(美国马萨诸塞州沃尔瑟姆)已签订了一项确定的协议,以获取私有分子诊断公司Mesa Biotech(美国加利福尼亚州圣地亚哥)的Mesa Biotech,以大约4.5亿美元的现金收购。
Más信息
2020年3月5日
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has announced that it plans to acquire QIAGEN N.V. (Venlo, Netherlands), a provider of molecular diagnostics and sample preparation technologies. Thermo Fisher's boards of directors and the managing board of QIAGEN have unanimously approved Thermo Fisher's proposal to acquire QIAGEN.
Más信息
2017年10月3日
Thermo Fisher Scientific’s liquid chromatography mass spectrometry (LC-MS) in vitro diagnostic (IVD) systems, which enable the quantitation of analytes in complex matrices, have received registration by Brazil’s National Health Surveillance Agency (ANVISA), allowing clinical laboratories in the country to now screen and quantify drugs efficiently.
Más信息